Chembond Material Technologies Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison
Chembond Material Technologies Ltd vs Tatva Chintan Pharma Chem Ltd Stock Comparison
Last Updated on: Mar 22, 2026
Key Highlights
The Latest Trading Price of Chembond Material Technologies Ltd is ₹ 127.55 as of 20 Mar 15:30
. The P/E Ratio of Chembond Material Technologies Ltd changed from 12.6 on March 2021 to 38.7 on March 2025 . This represents a CAGR of 25.16% over 5 yearsThe P/E Ratio of Tatva Chintan Pharma Chem Ltd changed from 53.4 on March 2022 to 278.3 on March 2025 . This represents a CAGR of 51.09% over 4 years The Market Cap of Chembond Material Technologies Ltd changed from ₹ 255.38 crore on March 2021 to ₹ 679.54 crore on March 2025 . This represents a CAGR of 21.62% over 5 yearsThe Market Cap of Tatva Chintan Pharma Chem Ltd changed from ₹ 5115 crore on March 2022 to ₹ 1588 crore on March 2025 . This represents a CAGR of -25.35% over 4 years The revenue of Chembond Material Technologies Ltd for the Dec '25 is ₹ 64.45 crore as compare to the Sep '25 revenue of ₹ 57.88 crore. This represent the growth of 11.35% The revenue of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 133.07 crore as compare to the Sep '25 revenue of ₹ 124.52 crore. This represent the growth of 6.87% The ebitda of Chembond Material Technologies Ltd for the Dec '25 is ₹ 3.9 crore as compare to the Sep '25 ebitda of ₹ 4.15 crore. This represent the decline of -6.02% The ebitda of Tatva Chintan Pharma Chem Ltd for the Dec '25 is ₹ 27.22 crore as compare to the Sep '25 ebitda of ₹ 23.22 crore. This represent the growth of 17.23% The net profit of Chembond Material Technologies Ltd changed from ₹ 4.68 crore to ₹ 1.59 crore over 7 quarters. This represents a CAGR of -46.04%
The net profit of Tatva Chintan Pharma Chem Ltd changed from ₹ 5.21 crore to ₹ 15.17 crore over 7 quarters. This represents a CAGR of 84.17%
The Dividend Payout of Chembond Material Technologies Ltd changed from 31.27 % on March 2021 to 13.66 % on March 2025 . This represents a CAGR of -15.26% over 5 yearsThe Dividend Payout of Tatva Chintan Pharma Chem Ltd changed from 19.56 % on March 2021 to 708.79 % on March 2025 . This represents a CAGR of 105.04% over 5 years .
About Chembond Material Technologies Ltd
Chembond Material Technologies Limited was initially incorporated as 'Chembond Material Chemicals Limited' in 1975.
The Company has changed the name to 'Chembond Material Technologies Limited' with effect from May 27, 2025, pursuant to the Composite Scheme of Arrangement.
Company is engaged in manufacturing of Speciality Chemicals.
The Company holds 49% interest in Chembond Enzyme Company Ltd, which supplies industrial enzymes for applications in textile, animal health and alcohol production.
It holds 49% interest in Henkel Chembond Surface Technologies Ltd, which manufactures metal treatment chemicals for applications in automobile, steel, appliance, engineering, defense, rail, aerospace and general industries.
It owns 51% interest in H2O Innovation (India) Limited, which offers equipment based solutions for water treatment recycle and reuse.
About Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Limited was formerly incorporated as 'Tatva Chintan Pharma Chem Private Limited' on 12 June 1996.
The status of the Company converted from Private Limited into a Public Limited Company from 27 January 2021 and the name of Company changed from 'Tatva Chintan Pharma Chem Private Limited' to 'Tatva Chintan Pharma Chem Limited'.
The Company is promoted by Mr. Chintan Nitin Kumar Shah, Mr. Ajay Kumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani.
The Company is a globally recognized specialty chemical player with several market leading products in its portfolio.
The Company is primarily engaged in manufacturing, distribution and selling of specialty chemicals i.e., Phase Transfer Catalysts (PTC), Structure Directing Agents (SDA), Electrolyte Salts and Solutions (ESS), Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals (PASC).
FAQs for the comparison of Chembond Material Technologies Ltd and Tatva Chintan Pharma Chem Ltd
Which company has a larger market capitalization, Chembond Material Technologies Ltd or Tatva Chintan Pharma Chem Ltd?
Market cap of Chembond Material Technologies Ltd is 171 Cr while Market cap of Tatva Chintan Pharma Chem Ltd is 2,637 Cr
What are the key factors driving the stock performance of Chembond Material Technologies Ltd and Tatva Chintan Pharma Chem Ltd?
The stock performance of Chembond Material Technologies Ltd and Tatva Chintan Pharma Chem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Chembond Material Technologies Ltd and Tatva Chintan Pharma Chem Ltd?
As of March 22, 2026, the Chembond Material Technologies Ltd stock price is INR ₹127.55. On the other hand, Tatva Chintan Pharma Chem Ltd stock price is INR ₹1127.45.
How do dividend payouts of Chembond Material Technologies Ltd and Tatva Chintan Pharma Chem Ltd compare?
To compare the dividend payouts of Chembond Material Technologies Ltd and Tatva Chintan Pharma Chem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.